Company: OXBRW
Filing Date: 2025-04-25
Form Type: S-3
Source: 0001641172-25-006292
Chunk: 25

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-04-25
Form: S-3
Chunk 25
---
 of our ordinary shares as of December 31, 2024. Assuming that all 8,230,700 ordinary shares are issued in connection with the exercise of Warrants, you will incur immediate and substantial dilution of approximately $3.00 per share. For a further description of the dilution that you will experience immediately after the exercise of the Warrants, see the section in this prospectus entitled “Dilution”.

You may experience future dilution as a result of future equity offerings.

In order to raise additional capital, we may in the future offer additional ordinary shares or other securities convertible into or exchangeable for our ordinary shares. Investors purchasing shares or other securities in the future could have rights superior to holders of our existing securities.

Furthermore, you could experience further dilution if outstanding options or warrants are exercised or if we issue additional ordinary shares. As of December 31, 2024, approximately 1,664,641 ordinary shares that are either subject to outstanding options or warrants, issuable upon vesting of outstanding restricted stock awards, or reserved for future issuance under our equity incentive plans are eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules.

Our management will have broad discretion over the use of the proceeds we receive from the exercise of the Warrants and might not apply the proceeds in ways that increase the value of your investment.

Our management will have broad discretion to use the net proceeds from the exercise of the Warrants, and you will be relying on the judgment of our management regarding the application of these proceeds. You will not have the opportunity to influence our decisions on how to use the proceeds, and the Company may not apply the net proceeds from the exercise of the Warrants in ways that increase the value of your investment. Because of the number and variability of factors that will determine our use of the net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. The failure by our management to apply these funds effectively could harm our business.

| 12 |

<div align='center'>USE OF PROCEEDS</div>

If the Warrants are exercised in full, we will receive proceeds of $61.7 million. However, we do not know when, if or the extent to which such Warrants may be exercised, and it is possible that no Warrants may be exercised, in which case we would not receive any proceeds from this offering.

We currently intend to use the net proceeds from the exercise of the Warrants for working capital and general